Media Partners

2020 News Coverage

Identifying Opportunities At The Interface Of Life Sciences And Tech
December 16, 2019| Mana Chandhok | Bio-IT World

A Regulatory View of Personalized Therapeutics

December 18, 2019 | Christina Lingham | Bio-IT World

Building Diagnostics With Data In Mind
December 18, 2019 | Kaitlin Searfoss Kelleher | Diagnostics World News

Scaling Precision Oncology
November 19, 2019 | Benjamin Ross | Diagnostics World News

A Digital Transformation at the City of Hope
December 19, 2019 | Mana Chandhok | Bio-IT World

2019 News Coverage

Young Scientists Present Diagnostic Solutions At Molecular Medicine Tri-Conference

April 10, 2019 | Benjamin Ross | Diagnostics World News

Point-Of-Care Testing And Diagnostics In Vietnam

April 9, 2019 | Benjamin Ross | Diagnostics World News

Microfluidic technologies are taking point-of-care testing to the next level

Mar 29, 2019 | Sébastien Clerc | Yole Development

Harnessing Machine Learning and Artificial Intelligence To Accelerate Discovery In Diagnostics

Mar 28, 2019 | Melissa Pandika | Diagnostics World News 

Sarah Gray And Arupa Ganguly on Remembering The Human Lives Behind Biospecimen Donations

Mar 28, 2019 | Melissa Pandika | Bio-IT World

Harnessing Machine Learning And Artificial Intelligence To Accelerate Discoveries: Updates From Bio-IT World West

Mar 26, 2019 | Melissa Pandika | Bio-IT World

How Mount Sinai Placed A Clinical Trial In The Palm Of Your Hand

March 22, 2019 | Benjamin Ross | Clinical Research News

Evolving Challenges And Directions In Data Commons: Updates From Bio-IT World West

Mar 22, 2019 | Melissa Pandika | Bio-IT World

Building A Credit Score For Health: Sapiens Data Science's Approach to Precision Medicine

Mar 20, 2019 | Benjamin Ross | Diagnostics World News

Academic, Community, and Health System Hospitals Face Unique Hurdles Implementing Precision Medicine

Mar 15, 2019 | Monica Heger | GenomeWeb

Novel Technologies, Machine Learning Are The Keys To Improving Acute Infection Diagnostics

February 13, 2019 | Kaitlin Kelleher | Diagnostics World News

Rapid Response And The Outbreaks To Come

February 1, 2019 | Kaitlin Kelleher | Diagnostics World News

Collaboration And Machine Learning Key For 23andMe's Drug Discovery 

January 31, 2019 | Mana Chandhok | Bio-IT World

EMERSE: How Better Big Data Search Could Change Healthcare

January 16, 2019 | Bio-IT World

 

2018 News Coverage

NCI Pediatric MATCH Trial Interim Data Shows 24 Percent of Patients Eligible for Targeted Therapy

May 16, 2019 | Christie Rizk | GenomeWeb

The Latest in Data Integration and Personalized Medicine: Updates from the 2018 Molecular Medicine Tri-Conference

March 5, 2018 | Melissa Pandika | Bio-IT World

UCLA Leverages Lab Standardization to Evaluate New POC Testing

March 12, 2018 | GenomeWeb Staff | GenomeWeb

As Cancer Immunotherapy Evolves, Challenges Compound for Diagnostic Development

February 28, 2018 | Molika Ashford | GenomeWeb

TriCore Considering Broader Launch of 16S Metagenomic Assay for Bacterial Dx

February 28, 2018 | John Gilmore | GenomeWeb

Leroy Hood On How Systems-Driven 21st Century Medicine Could Transform Healthcare

February 27, 2018 | Melissa Pandika | Diagnotics World

Share The Data: David Haussler Envisions A New Future For Pediatric Cancer

February 22, 2018  |  Leah Rosenbaum | Bio-IT World

Cofactor Pushes RNA-Based Dx Goals With New Immuno-Oncology Assay

February 16, 2018 | Molika Ashford | GenomeWeb

Startup Anitoa Systems Opens Early-Access Program for Portable qPCR System

February 15, 2018 | Madeleine Johnson | GenomeWeb

Diagnostics World Announces Winner Of Early Innovator Awards Program

February 14, 2018 | Diagnotics World Staff | Diagnotics World

UCSC Pediatric Cancer Effort Finds Success Using Gene Expression Data to Match Patients to Treatments

February 14, 2018 | Christie Rizk | GenomeWeb

 

2017 News Coverage

Dutch Team Refining Blood-Based Dx Platform Acquired by Illumina Last Year

Mar 10, 2017 | Justin Petrone | GenomeWeb

Startup TwinStrand Biosciences Aims to Commercialize Duplex Sequencing Technology

Mar 09, 2017 | Monica Heger | GenomeWeb

Integrated Future: GeneInsight’s New Home At Sunquest

March 6, 2017 | By Allison Proffitt | Bio-IT World

An Industry Goes for the Gut

March 2, 2017 | Regina McEnery | eureka

Despite Actionable Results, Cancer Sequencing Projects Struggle to Get Patients on Targeted Drugs

Mar 01, 2017 | Monica Heger | GenomeWeb

Raw Materials: iSpecimen Marketplace Platform Makes It Easy To Find Biospecimens

February 24, 2017 | By Allison Proffitt | Bio-IT World

UCSF Lab Readies Launch of Metagenomic NGS Test for Infectious Disease

Feb 24, 2017 | Monica Heger | GenomeWeb

An Immunological Ignition Switch

February 23, 2017 | Regina McEnery | eureka

Our Body’s Natural Born

February 22, 2017 | Regina McEnery | eureka

Diagnostics World Announces Winner of Inaugural Early Innovator Awards Program

February 22, 2017 | By Diagnostics World Staff | Diagnostics World


2016 News Coverage

Biocept's Dual Platform for Liquid Biopsies

March 15, 2016 | Aaron Krol | Diagnostics World

Notes from the 2016 Molecular Medicine Tri-Conference

March 14, 2016 | Diagnostics World Staff | Diagnostics World

Xcell's New Incubator Promises Lifelike Conditions for Tests on Primary Cells

March 14, 2016 | Aaron Krol | Diagnostics World

At Tri-Con, Groups Detail NGS-Based Strategies to Detect ctDNA Mutations at Ever-Lower Frequencies

March 11, 2016 | Monica Heger | GenomeWeb

Startup Miroculus Shares Vision for Rapid, Inexpensive miRNA Diagnostics at Tri-Con

March 9, 2016 | Ben Butkus | GenomeWeb

Must See Talks on Big Data and Informatics at TRI-CON 2016

February 10, 2016 | Zachary Helminiak | SLONE Partners

Molecular Medicine Tri-Conference in San Francisco March 6-11; BioQuick News Is a Media Sponsor

February 20, 2016 | Staff Writer | bioquicknews

10 Must See Talks at TRI-CON 2016

February 10, 2016 | Zachary Helminiak | SLONE Partners

Visit the preeminent event on molecular medicine

February 1, 2016 | Lloyd Dunlap | DDNews

Fluoresentric on the Right Pitch to Capitalize a Diagnostic Technology

August 4, 2015 | Diagnostics World Staff | Diagnostics World


2015 News Coverage

TRICON: HI’s Molecular Medicine Tri-Conference Kicks Off Despite Holiday, Slowed Travel

February 16, 2015 | BioSpace | Riley McDermid

Maverix Biomics and Elsevier Sign NGS Data Interpretation Agreement

February 16, 2015 | Bio-IT World Staff | Bio-IT World

BIOVIA Launches Biologics Informatics Program

February 17, 2015 | Bio-IT World Staff | Bio-IT World

News and Notes from TriCon 2015

February 19, 2015 | Bio-IT World Staff | Bio-IT World

Guardant Health, Collaborators Present Clinical Validity Data for ctDNA Assay

February 20, 2015 | Monica Heger | GenomeWeb

Multiplicom, Premaitha Develop CE-IVDs for Noninvasive Prenatal Testing in Europe

February 24, 2015 | Monica Heger | GenomeWeb

Personal Genome Diagnostics Aims for FDA Clearance of NGS-based Cancer Products

February 24, 2015 | Monica Heger | GenomeWeb

Reporter’s Notebook: Molecular Medicine Tri Conference 2015

February 27, 2015 | Aaron Krol | Bio-IT World

Point-of-Care Diagnostics at the 22nd International Molecular Medicine Tri-Conference

April 22, 2015 | Robert L Stevenson, PhD | American Laboratory


2014 News Coverage

With New Tools, Physicians Become Better NGS Customers

Mar 15 | GEN | Scientists who study how physicians use genomics data in personalized medicine presented their recent work at the Cambridge Healthtech Molecular Med Tri Conference in San Francisco.

Startup Guardant Health Developing NGS-based Assays to Assess Circulating Tumor DNA

Mar 5 | Clinical Sequencing News | At last month's Molecular Medicine Tri-Conference in San Francisco, Dave Hoon, the director of the John Wayne Cancer Institute's sequencing center and an advisor to the company, presented a validation study he is doing with the company, results of which have been analyzed in around 250 patients so far.

Singapore's MiRxes Spins Out from A*Star with Novel qPCR Assay Platform for microRNA Analysis

Feb 27 | MiRxes CTO Lihan Zhou and other company officials presented posters describing the mSMRT-qPCR technology and MiRxes' efforts to apply it to the non-invasive early detection of gastric and breast cancers earlier this month at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference in San Francisco.

Q&A: UMich's Muneesh Tewari on miRNAs as Cancer Biomarkers, ddPCR as Detection Method

Feb 27 | PCR Insider | Earlier this month at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference in San Francisco, Tewari presented some of his recent work in this area. He highlighted the fact that research on circulating miRNAs as cancer biomarkers is now nearing the six-year mark, and reviewed what researchers have learned and where they go from here.

UCSF, QB3 Team Developing PCR-Activated Cell Sorting Method; Startup Mission Bio Eyes Market

Feb 20 | PCR Insider | Abate shared details of the new method in a presentation last week at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference in San Francisco.

MolecularHealth Readies NGS-based Oncology Assays

Feb 19 | Clinical Sequencing News | MolecularHealth is in the final stages of validating a targeted sequencing panel and an exome sequencing test for cancer patients and plans to launch the tests within the next couple of months, the company told Clinical Sequencing News at last week's Molecular Medicine Tri Conference in San Francisco.

Patient Stratification in Clinical Trials Emerges as Theme at MMTC

Feb 17 | Bio-IT World | The 21st annual Molecular Medicine Tri-Conference in San Francisco featured some intense scrutiny of one area where genetic knowledge is ready to make an impact today: better defining the best patient populations for treatment during clinical trials.

At Threshold of Detection, False-Positive Droplets a Nuisance in ddPCR

Feb 13 | PCR Insider | In a presentation this week at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference in San Francisco, Strain stated definitively that real-time PCR is "not good enough" for the detection of residual HIV nucleic acids in patient samples, and provided additional evidence generated in his lab that droplet digital PCR is an ideal modality for this application.

Rheonix Unveils 'Channel-Free' Microfluidic Device for Molecular Testing Platform

Feb 13 | PCR Insider | In a presentation in the Biospecimen Science and Sample Prep program of Cambridge Healthtech Institute's Molecular Medicine Tri-Conference, held here this week, Richard Montagna, Rheonix's senior vice president for scientific and clinical affairs, discussed the company's latest microfluidics breakthrough, the Smart FilmCARD.

Denmark's Anapa Biotech Applies Primer-Modification Tech to MRSA Assay; Discloses NextGen Molecule

Feb 13 | PCR Insider | Schneider discussed these developments at a presentation during the "PCR for Molecular Medicine" track at Cambridge Healthcare Institute's Molecular Medicine Tri-Conference, held here this week.

Sample Prep Proving a Key Consideration in Clinical NGS Testing

Feb 12 | Clinical Sequencing News | Increasingly, issues related to sample prep, not sequencing technology, are becoming the hurdle for developing clinical next-gen sequencing-based tests, researchers from Quest Diagnostics and the US Centers for Disease Control and Prevention said at this week's Molecular Medicine Tri Conference in San Francisco.

Informatics Tools for the Big Data Challenge

Jan 03 | Bio-IT World |Informatics tools are essential to enabling life sciences research, and at the Molecular Medicine Tri-Conference next month in San Francisco, a host of leaders across the industry will share their best practices for making sense of the wealth.

Clinical Sequencing at the Molecular Medicine Tri-Conference

Jan 02 | Clinical Informatics News | 2014 will be the biggest year yet for the clinical use of genetic information. At the Molecular Medicine Tri-Conference in February, speakers from biotech industry and research will discuss the future of clinical sequencing, whether in cancer treatment, diagnostics, prenatal testing, or just general care.

Maven Biotech Undertakes Asset Sale to Deliver Label-free Detection Technology into 'Stronger Hands'

Dec 17 | BioArray News| Blose said that Maven's technology is "already receiving attention" from undisclosed parties, and that BioMed intends to meet with potential partners at the upcoming JP Morgan Healthcare Conference in San Francisco in January, and again at the Molecular Medicine Tri-Conference, which will also be held in San Francisco, in February.


Premier Sponsors

NeoGenomics

Seegene